Skip to main content

Yale University

Search form

Yale Law School Center for the Study of Corporate Law

Students in Chirelstein Colloquium with Arthur Fleischer, Jr. '58, Partner, Fried, Frank, Harris, Shriver & Jacobson LLP
H. Rodgin Cohen, Partner, Sullivan & Cromwell, in 2009 Industry Perspectives on the Global Financial Crisis Series
H. Rodgin Cohen, Partner, Sullivan & Cromwell, in 2009 Industry Perspectives on the Global Financial Crisis Series
Students at the 2009 Winter Lecture with U. Chicago Booth Prof. Steven N. Kaplan
Students at the 2009 Winter Lecture with U. Chicago Booth Prof. Steven N. Kaplan
Arthur Fleischer, Jr. '58, Partner, Fried, Frank, Harris, Shriver & Jacobson LLP, presenting at Chirelstein Colloquium
Students in Chirelstein Colloquium with Arthur Fleischer, Jr. '58, Partner, Fried, Frank, Harris, Shriver & Jacobson LLP
Arthur Fleischer, Jr. '58, Partner, Fried, Frank, Harris, Shriver & Jacobson LLP, presenting at Chirelstein Colloquium
Audience at 2009 Industry Perspectives on the Global Financial Crisis Series
  • Main Menu
  • Sub Menu

You are here

Home » Activities » Alumni Breakfasts » November 8, 2018: "Law, Finance, and Innovation in Pharmaceutical R&D"

November 8, 2018: “Law, Finance, and Innovation in Pharmaceutical R&D”

  1. Esther S. Kim & Andrew W. Lo, The “New” Venture Philanthropy: A Case Study of the Cystic Fibrosis Foundation (Jul. 4, 2017 version)
  2. Adam Jorring, Andrew W. Lo, Tomas J. Philipson, Manita Singh, & Richard T. Thakor, Sharing R&D Risk in Healthcare via FDA Hedges (Working Paper; January 2018 Draft)
  3. Andrew W. Lo & Sourya V. Naraharisetti, Special Case Studies: New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, 12(1) Journal of Investment Management 4 (2014)
  4. Vivek Ramaswamy, Video of Remarks at the First Annual Roivant Pipeline Day
  5. Randall Smith, The Private Equity Firm that Quietly Profits on Top-Selling Drugs, New York Times, Jul. 8, 2017
  6. Richard T. Thakor, Nicholas Anaya, Yuwei Zhang, Christian Vilanilam, Kien Wei Siah, Chi Heem Wong, & Andrew W. Lo, Just how good an investment is the biopharmaceutical sector?, 35(12) Nature Biotechnology (2017)
  7. Richard T. Thakor, Nicholas Anaya, Yuwei Zhang, Christian Vilanilam, Kien Wei Siah, Chi Heem Wong, & Andrew W. Lo, Supplementary Information for: Just how good an investment is the biopharmaceutical sector? (Working Paper)
  8. Teresa Watanabe, UCLA will get hundreds of millions for rights to prostate cancer drug, Los Angeles Times (Mar. 4, 2016)
  9. Janet Woodcock, Expediting drug development for serious illness: Trade-offs between patient access and certainty, 15(3) Clinical Trials 230 (2018)
  •  
  • Top
  • Home
  • Upcoming Events
  • Organization
  • History of Business Law at Yale
  • Activities
  • Business Law Curriculum at Yale
  • Joint Degrees
  • Simeon E. Baldwin Award
  • Working Papers
  • Endowed Funds
  • Related Links
  • Yale Law School

Yale University

Copyright © 2023 Yale University · All rights reserved · Privacy policy

  • Facebook
  • Twitter
  • Flickr
  • iTunes
  • YouTube